Home Pharmaceuticals Global Radiopharmaceutical Market Size, Growth, Future Scope, Forecast to 2033

Radiopharmaceutical Market Size, Share & Trends Analysis Report By Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), By Application (Cardiology, Oncology, Neurology, Bone Metastasis, Thyroid, Endocrine Tumors), By Radioisotope (Iodine I, Gallium 68, Others, Technetium 99m, Fluorine 18), By End User (Hospitals and clinics, Medical Imaging centers, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2025-2033

Report Code: SRPH626DR
Last Updated : Feb 13, 2025
Author : Debashree Bora
Starting From
USD 2300
Buy Now

Table Of Content

  1. Executive Summary

    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends

    1. Global Radiopharmaceutical Market Introduction
    2. By Radioisotopes Type
      1. Introduction
        1. Radioisotopes Type By Value
      2. Technetium 99
        1. By Value
      3. Fluorine 18
        1. By Value
      4. Iodine 131
        1. By Value
      5. Lutetium 177
        1. By Value
      6. Yttrium 90
        1. By Value
      7. Radium-223
        1. By Value
      8. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Diagnostics 
        1. By Value
      3. Therapeutics
        1. By Value
    4. By Source
      1. Introduction
        1. Source By Value
      2. Cyclotrons
        1. By Value
      3. Nuclear Reactors
        1. By Value
      4. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Medical Imaging Centers
        1. By Value
      4. Cancer Research Institute
        1. By Value
      5. Other
        1. By Value
    1. Introduction
    2. By Radioisotopes Type
      1. Introduction
        1. Radioisotopes Type By Value
      2. Technetium 99
        1. By Value
      3. Fluorine 18
        1. By Value
      4. Iodine 131
        1. By Value
      5. Lutetium 177
        1. By Value
      6. Yttrium 90
        1. By Value
      7. Radium-223
        1. By Value
      8. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Diagnostics 
        1. By Value
      3. Therapeutics
        1. By Value
    4. By Source
      1. Introduction
        1. Source By Value
      2. Cyclotrons
        1. By Value
      3. Nuclear Reactors
        1. By Value
      4. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Medical Imaging Centers
        1. By Value
      4. Cancer Research Institute
        1. By Value
      5. Other
        1. By Value
    6. U.S.
      1. By Radioisotopes Type
        1. Introduction
          1. Radioisotopes Type By Value
        2. Technetium 99
          1. By Value
        3. Fluorine 18
          1. By Value
        4. Iodine 131
          1. By Value
        5. Lutetium 177
          1. By Value
        6. Yttrium 90
          1. By Value
        7. Radium-223
          1. By Value
        8. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Diagnostics 
          1. By Value
        3. Therapeutics
          1. By Value
      3. By Source
        1. Introduction
          1. Source By Value
        2. Cyclotrons
          1. By Value
        3. Nuclear Reactors
          1. By Value
        4. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Medical Imaging Centers
          1. By Value
        4. Cancer Research Institute
          1. By Value
        5. Other
          1. By Value
    7. Canada
    1. Introduction
    2. By Radioisotopes Type
      1. Introduction
        1. Radioisotopes Type By Value
      2. Technetium 99
        1. By Value
      3. Fluorine 18
        1. By Value
      4. Iodine 131
        1. By Value
      5. Lutetium 177
        1. By Value
      6. Yttrium 90
        1. By Value
      7. Radium-223
        1. By Value
      8. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Diagnostics 
        1. By Value
      3. Therapeutics
        1. By Value
    4. By Source
      1. Introduction
        1. Source By Value
      2. Cyclotrons
        1. By Value
      3. Nuclear Reactors
        1. By Value
      4. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Medical Imaging Centers
        1. By Value
      4. Cancer Research Institute
        1. By Value
      5. Other
        1. By Value
    6. U.K.
      1. By Radioisotopes Type
        1. Introduction
          1. Radioisotopes Type By Value
        2. Technetium 99
          1. By Value
        3. Fluorine 18
          1. By Value
        4. Iodine 131
          1. By Value
        5. Lutetium 177
          1. By Value
        6. Yttrium 90
          1. By Value
        7. Radium-223
          1. By Value
        8. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Diagnostics 
          1. By Value
        3. Therapeutics
          1. By Value
      3. By Source
        1. Introduction
          1. Source By Value
        2. Cyclotrons
          1. By Value
        3. Nuclear Reactors
          1. By Value
        4. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Medical Imaging Centers
          1. By Value
        4. Cancer Research Institute
          1. By Value
        5. Other
          1. By Value
    7. Germany
    8. France
    9. Spain
    10. Italy
    11. Russia
    12. Nordic
    13. Benelux
    14. Rest of Europe
    1. Introduction
    2. By Radioisotopes Type
      1. Introduction
        1. Radioisotopes Type By Value
      2. Technetium 99
        1. By Value
      3. Fluorine 18
        1. By Value
      4. Iodine 131
        1. By Value
      5. Lutetium 177
        1. By Value
      6. Yttrium 90
        1. By Value
      7. Radium-223
        1. By Value
      8. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Diagnostics 
        1. By Value
      3. Therapeutics
        1. By Value
    4. By Source
      1. Introduction
        1. Source By Value
      2. Cyclotrons
        1. By Value
      3. Nuclear Reactors
        1. By Value
      4. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Medical Imaging Centers
        1. By Value
      4. Cancer Research Institute
        1. By Value
      5. Other
        1. By Value
    6. China
      1. By Radioisotopes Type
        1. Introduction
          1. Radioisotopes Type By Value
        2. Technetium 99
          1. By Value
        3. Fluorine 18
          1. By Value
        4. Iodine 131
          1. By Value
        5. Lutetium 177
          1. By Value
        6. Yttrium 90
          1. By Value
        7. Radium-223
          1. By Value
        8. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Diagnostics 
          1. By Value
        3. Therapeutics
          1. By Value
      3. By Source
        1. Introduction
          1. Source By Value
        2. Cyclotrons
          1. By Value
        3. Nuclear Reactors
          1. By Value
        4. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Medical Imaging Centers
          1. By Value
        4. Cancer Research Institute
          1. By Value
        5. Other
          1. By Value
    7. Korea
    8. Japan
    9. India
    10. Australia
    11. Taiwan
    12. South East Asia
    13. Rest of Asia-Pacific
    1. Introduction
    2. By Radioisotopes Type
      1. Introduction
        1. Radioisotopes Type By Value
      2. Technetium 99
        1. By Value
      3. Fluorine 18
        1. By Value
      4. Iodine 131
        1. By Value
      5. Lutetium 177
        1. By Value
      6. Yttrium 90
        1. By Value
      7. Radium-223
        1. By Value
      8. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Diagnostics 
        1. By Value
      3. Therapeutics
        1. By Value
    4. By Source
      1. Introduction
        1. Source By Value
      2. Cyclotrons
        1. By Value
      3. Nuclear Reactors
        1. By Value
      4. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Medical Imaging Centers
        1. By Value
      4. Cancer Research Institute
        1. By Value
      5. Other
        1. By Value
    6. UAE
      1. By Radioisotopes Type
        1. Introduction
          1. Radioisotopes Type By Value
        2. Technetium 99
          1. By Value
        3. Fluorine 18
          1. By Value
        4. Iodine 131
          1. By Value
        5. Lutetium 177
          1. By Value
        6. Yttrium 90
          1. By Value
        7. Radium-223
          1. By Value
        8. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Diagnostics 
          1. By Value
        3. Therapeutics
          1. By Value
      3. By Source
        1. Introduction
          1. Source By Value
        2. Cyclotrons
          1. By Value
        3. Nuclear Reactors
          1. By Value
        4. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Medical Imaging Centers
          1. By Value
        4. Cancer Research Institute
          1. By Value
        5. Other
          1. By Value
    7. Turkey
    8. Saudi Arabia
    9. South Africa
    10. Egypt
    11. Nigeria
    12. Rest of MEA
    1. Introduction
    2. By Radioisotopes Type
      1. Introduction
        1. Radioisotopes Type By Value
      2. Technetium 99
        1. By Value
      3. Fluorine 18
        1. By Value
      4. Iodine 131
        1. By Value
      5. Lutetium 177
        1. By Value
      6. Yttrium 90
        1. By Value
      7. Radium-223
        1. By Value
      8. Others
        1. By Value
    3. By Application
      1. Introduction
        1. Application By Value
      2. Diagnostics 
        1. By Value
      3. Therapeutics
        1. By Value
    4. By Source
      1. Introduction
        1. Source By Value
      2. Cyclotrons
        1. By Value
      3. Nuclear Reactors
        1. By Value
      4. Others
        1. By Value
    5. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Medical Imaging Centers
        1. By Value
      4. Cancer Research Institute
        1. By Value
      5. Other
        1. By Value
    6. Brazil
      1. By Radioisotopes Type
        1. Introduction
          1. Radioisotopes Type By Value
        2. Technetium 99
          1. By Value
        3. Fluorine 18
          1. By Value
        4. Iodine 131
          1. By Value
        5. Lutetium 177
          1. By Value
        6. Yttrium 90
          1. By Value
        7. Radium-223
          1. By Value
        8. Others
          1. By Value
      2. By Application
        1. Introduction
          1. Application By Value
        2. Diagnostics 
          1. By Value
        3. Therapeutics
          1. By Value
      3. By Source
        1. Introduction
          1. Source By Value
        2. Cyclotrons
          1. By Value
        3. Nuclear Reactors
          1. By Value
        4. Others
          1. By Value
      4. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Medical Imaging Centers
          1. By Value
        4. Cancer Research Institute
          1. By Value
        5. Other
          1. By Value
    7. Mexico
    8. Argentina
    9. Chile
    10. Colombia
    11. Rest of LATAM
    1. Radiopharmaceutical Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. PharmaLogic
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Siemens Healthineers AG 
    3. Cardinal Health
    4. Bayer AG
    5. IBA Radiopharma Solutions
    6. Curium
    7. Eckert and Ziegler 
    8. NTP
    9. Sinotau Pharmaceutical Group
    10. Novartis AG
    11. Eli Lilly and Company
    12. NMR
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Market Overview The global biopharmaceutical logistics market size was valued at USD 118.45 billion in 2022. It is projected to reach USD 198.93 billion by 2031, growing at a CAGR of 5.93% during the forecast period (2023–2031). Biopharm
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report


We are featured on :